Evil Alcohol

The update on NVLT is on it's way, but I went through a week of a binge vodka tonic action. Not good and got some sort of evil death virus. I'm on the rebound now so check back soon. Thanks.

Coming Today: NVLT

NVLT:

Novelos Therapeutics, Inc., a biopharmaceutical company, commercializes oxidized glutathione-based compounds for the treatment of cancer and hepatitis in the United States. Its products in development include NOV-002, which acts as a chemoprotectant and an immunomodulator; and NOV-205, which acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. NOV-002, a small-molecule formulation of a natural metabolite, is in Phase III development for lung cancer, as well as in Phase II development for chemotherapy-resistant ovarian cancer and early-stage breast cancer. NOV-002 is also being developed for acute radiation injury. NOV-205, a small-molecule formulation of oxidized glutathione and inosine, is in Phase Ib development for the treatment of chronic hepatitis C. Novelos Therapeutics is based in Newton, Massachusetts.

I need to do some research on the compounds--eg how they work etc, and will post. Very interesting mechanisms of action.